Q3 2024 Holdings
Filed 2024-11-13 | 30 holdings | $339.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Neurogene Inc(NGNE) | COM | 64135M105 | $42.1M | 1,004,291 | 12.4% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $24.5M | 2,128,773 | 7.2% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $21.4M | 1,910,121 | 6.3% |
| Evolus Inc(EOLS) | COM | 30052C107 | $19.0M | 1,170,000 | 5.6% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $17.1M | 750,000 | 5.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $16.7M | 316,000 | 4.9% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $15.0M | 1,299,503 | 4.4% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $14.8M | 1,326,234 | 4.3% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $13.6M | 6,934,982 | 4.0% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $13.3M | 3,263,672 | 3.9% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $12.6M | 514,659 | 3.7% |
| Merus N V | COM | N5749R100 | $12.5M | 250,000 | 3.7% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $11.9M | 1,000,000 | 3.5% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $10.2M | 255,000 | 3.0% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $10.2M | 2,811,955 | 3.0% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $9.6M | 758,786 | 2.8% |
| Optinose Inc | COM | 68404V100 | $8.6M | 12,861,136 | 2.5% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $8.4M | 100,000 | 2.5% |
| Arcellx Inc(ACLX)Put | COMMON STOCK | 03940C100 | $8.4M | 100,000 | 2.5% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $7.5M | 275,000 | 2.2% |
| Outlook Therapeutics Inc(OTLK) | COM | 69012T305 | $6.9M | 1,293,028 | 2.0% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $6.1M | 322,380 | 1.8% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $5.6M | 959,953 | 1.7% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $5.2M | 500,000 | 1.5% |
| Tscan Therapeutics Inc(TCRX) | COM | 89854M101 | $5.1M | 1,016,375 | 1.5% |
| Unicycive Therapeutics Inc | COM | 90466Y103 | $3.5M | 8,559,000 | 1.0% |
| Promis Neurosciences Inc(PMNEUR) | COM NEW | 74346M406 | $3.5M | 2,790,698 | 1.0% |
| Cartesian Therapeutics Inc(RNAC) | COM NEW | 816212302 | $3.2M | 200,000 | 0.9% |
| Vistagen Therapeutics Inc(VTGN) | COM | 92840H400 | $2.0M | 674,075 | 0.6% |
| Eliem Therapeutics Inc(CLYM) | COM | 28658R106 | $1.3M | 248,168 | 0.4% |